facebook
twitter
search
search

SSDS gets Israeli backing

April 3, 2013 at 1:46 PM

NEW YORK, April 3 (UPI) -- An Israeli investment management company plans to help fund Suspect Detection Systems Inc., a U.S. developer counter-terror and crime-prevention technologies.

The funding by BioMedix Ltd. would come through a share swap arrangement.

Under the deal, BioMedix will buy 5,229,659 restricted SDSS shares for 4 cents per share using its subsidiary Gefen Biomed Investments Ltd. Suspect Detection Systems will receive 921,790 shares of Gefen.

"SDSS continues to progress in its efforts to bring added value to our shareholders," said SDSS Chief Executive Officer Gil Boosidan. "The funding that we receive upon from our sale of our Gefen shares can be used to enhance our ability to add personnel and acquire resources and support our marketing efforts to achieve projects with strategic partners.

"Suspect Detection Systems Inc. is continuing its efforts to improve cash flow, which will also improve our financial condition and should result in share price appreciation. Our long-term plan includes seeking to upgrade our share listings to higher level exchanges including foreign listings in the future."

Suspect Detection Systems manufactures a system call Cogito, an interrogatory system that detects the hidden "hostile intent" of assailants before they commit their intended acts with a high degree of accuracy.

The system can also be used after a crime is committed to quickly identify criminals from among a general population pool.

Like Us on Facebook for more stories from UPI.com  
Related UPI Stories
Latest Headlines
Top Stories
Houston-based LINN leaves Texas shale
Australian troops to receive new rifle variant
Saab joining BAE Systems, Patria in bid to produce armored vehicle
Kurdish government in Iraq selling more oil
Gas prices could go up, AAA says